Precision Genomic Medicine and the UK

I just returned from the UK, where I attended a Ditchley Foundation Conference on machine learning and genetic engineering. The attendees included scientists, government officials, venture capitalists, ethicists, and medical professionals. The UK could become the world leader in genomic research by combining population-level genotyping with NHS health records. The application of AI to datasets …


The Future of Genomic Precision Medicine

As I mentioned in this earlier post, I’ll be in the UK next week for a Ditchley Foundation conference on the intersection of machine learning and genetic engineering. I’ll present these slides at the meeting. The slides review the rapidly evolving situation in genomic prediction, focusing on disease risk predicted using inexpensive genotyping. There are now …


IQ (Institute for Quantitative Health Science and Engineering) at MSU

  Chris Contag is the founding director of the Institute for Quantitative Health Science and Engineering and the chairperson of the new Department of Biomedical Engineering in the College of Engineering. Contag was previously a professor in the Departments of Pediatrics, Radiology, Bioengineering and Microbiology and Immunology at Stanford University. He held the titles of …


Homo Sapiens 2.0? (Jamie Metzl, TechCrunch)

Jamie Metzl writes in TechCrunch. Homo Sapiens 2.0? We need a species-wide conversation about the future of human genetic enhancement: After 4 billion years of evolution by one set of rules, our species is about to begin evolving by another. Overlapping and mutually reinforcing revolutions in genetics, information technology, artificial intelligence, big data analytics, and …


Fear Not!

For relentless technological advance, powered by high g researchers, venture capitalists, capital markets, and government investment in basic research, continues to deliver a cornucopia of benefits to the average joe. (Note, however, that Moore’s Law itself has stalled out recently …) Tweet